These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8203304)

  • 41. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
    Pica-Mattoccia L; Cioli D
    Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An 18-month study of the parasitologic and tumorigenic effects of hycanthone in Schistosoma mansoni-infected and noninfected mice.
    Yarinsky A; Drobeck HP; Freele H; Wiland J; Gumaer KI
    Toxicol Appl Pharmacol; 1974 Jan; 27(1):169-82. PubMed ID: 4850561
    [No Abstract]   [Full Text] [Related]  

  • 43. Anthelmintic activity of the natural compound (+)-limonene epoxide against Schistosoma mansoni.
    Moraes Jd; Almeida AA; Brito MR; Marques TH; Lima TC; Sousa DP; Nakano E; Mendonça RZ; Freitas RM
    Planta Med; 2013 Mar; 79(3-4):253-8. PubMed ID: 23408270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macromolecular bases of antischistosomal therapy.
    Angelucci F; Miele AE; Boumis G; Brunori M; Dimastrogiovanni D; Bellelli A
    Curr Top Med Chem; 2011; 11(16):2012-28. PubMed ID: 21619508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hycanthone: a review of its experimental chemotherapy, pharmacology and toxicology.
    Farah A; Berberian DA; Davison C; Dennis EW; Donikian MA; Drobeck HP; Ferrari RA; Yarinsky A
    Egypt J Bilharz; 1974; 1(2):181-95. PubMed ID: 4220100
    [No Abstract]   [Full Text] [Related]  

  • 46. The potential of artemether for the control of schistosomiasis.
    Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
    Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.
    Abdul-Ghani R; Loutfy N; el-Sahn A; Hassan A
    Parasitol Res; 2009 Apr; 104(5):955-65. PubMed ID: 19255786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study of the mode of action of hycanthone against Schistosoma mansoni in vivo and in vitro.
    Cioli D; Knopf PM
    Am J Trop Med Hyg; 1980 Mar; 29(2):220-6. PubMed ID: 7369442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug resistance in human helminths: current situation and lessons from livestock.
    Geerts S; Gryseels B
    Clin Microbiol Rev; 2000 Apr; 13(2):207-22. PubMed ID: 10755998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of schistosomiasis mansoni].
    de Carvalho SA
    Rev Paul Med; 1982; 99(2):26-8. PubMed ID: 7156674
    [No Abstract]   [Full Text] [Related]  

  • 53. [Research progress of the evaluation methods on the resistance of schistosome to praziquantel].
    Guo J; Guo JG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):182-4. PubMed ID: 16300016
    [No Abstract]   [Full Text] [Related]  

  • 54. Anthelmintic resistance in human helminths: a review.
    Geerts S; Gryseels B
    Trop Med Int Health; 2001 Nov; 6(11):915-21. PubMed ID: 11703846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Schistosomiasis control: keep taking the tablets.
    Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
    Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of some tetrahydro- and pyrazinoquinolines against early developing forms of Schistosoma mansoni.
    Pellegrino J; Pereira LH; Mello RT; Katz N
    J Parasitol; 1974 Aug; 60(4):723-5. PubMed ID: 4850406
    [No Abstract]   [Full Text] [Related]  

  • 57. [Hepatopathy after treatment of schistosomiasis mansoni with hycanthone. II. Report of a case of death after 30 days of treatment].
    Godoy P; de Oliveira MC; Raso P; Marinho RP; Neves J
    Rev Inst Med Trop Sao Paulo; 1974 Mar; 16(2):114-20. PubMed ID: 4845458
    [No Abstract]   [Full Text] [Related]  

  • 58. Chemotherapeutic effects on larval stages of Schistosoma mansoni during infection and re-infection of mice.
    Silva LM; Menezes RM; de Oliveira SA; Andrade ZA
    Rev Soc Bras Med Trop; 2003; 36(3):335-41. PubMed ID: 12908033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anthelmintic activity of triclabendazole.
    Coles GC
    J Helminthol; 1986 Sep; 60(3):210-2. PubMed ID: 3745874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of 35972 RP (oltipraz) a new antischistosomal drug against Schistosoma haematobium, Schistosoma mansoni, and Schistosoma intercalatum.
    Gentilini M; Duflo B; Richard-Lenoble D; Brücker G; Danis M; Niel G; Meunier Y
    Acta Trop; 1980 Sep; 37(3):271-4. PubMed ID: 6106367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.